GMED
Price
$50.43
Change
+$0.64 (+1.29%)
Updated
May 1, 6:59 PM EST
5 days until earnings call
HOLX
Price
$76.27
Change
+$0.49 (+0.65%)
Updated
May 1, 6:59 PM EST
Earnings call today
Ad is loading...

Compare predictions GMED vs HOLX

Header iconGMED vs HOLX Comparison
Open Charts GMED vs HOLXBanner chart's image
Globus Medical
Price$50.43
Change+$0.64 (+1.29%)
Volume$227.46K
CapitalizationN/A
Hologic
Price$76.27
Change+$0.49 (+0.65%)
Volume$752.27K
CapitalizationN/A
View a ticker or compare two or three
GMED vs HOLX Comparison Chart

Loading...

GMEDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HOLXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
GMED vs. HOLX commentary
May 02, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMED is a StrongSell and HOLX is a Hold.

COMPARISON
Comparison
May 02, 2024
Stock price -- (GMED: $50.43 vs. HOLX: $76.28)
Brand notoriety: GMED and HOLX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: GMED: 90% vs. HOLX: 72%
Market capitalization -- GMED: $7.19B vs. HOLX: $17.87B
GMED [@Medical Specialties] is valued at $7.19B. HOLX’s [@Medical Specialties] market capitalization is $17.87B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.44B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GMED’s FA Score shows that 1 FA rating(s) are green whileHOLX’s FA Score has 2 green FA rating(s).

  • GMED’s FA Score: 1 green, 4 red.
  • HOLX’s FA Score: 2 green, 3 red.
According to our system of comparison, HOLX is a better buy in the long-term than GMED.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GMED’s TA Score shows that 2 TA indicator(s) are bullish while HOLX’s TA Score has 7 bullish TA indicator(s).

  • GMED’s TA Score: 2 bullish, 5 bearish.
  • HOLX’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, HOLX is a better buy in the short-term than GMED.

Price Growth

GMED (@Medical Specialties) experienced а -1.96% price change this week, while HOLX (@Medical Specialties) price change was -0.56% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -0.66%. For the same industry, the average monthly price growth was -4.39%, and the average quarterly price growth was +12.07%.

Reported Earning Dates

GMED is expected to report earnings on Aug 01, 2024.

HOLX is expected to report earnings on Jul 24, 2024.

Industries' Descriptions

@Medical Specialties (-0.66% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for GMED with price predictions.
OPEN
A.I.dvisor published
a Summary for HOLX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
HOLX($17.9B) has a higher market cap than GMED($7.19B). GMED has higher P/E ratio than HOLX: GMED (49.65) vs HOLX (36.08). HOLX YTD gains are higher at: 6.760 vs. GMED (-5.367). HOLX has higher annual earnings (EBITDA): 1.06B vs. GMED (347M). HOLX has more cash in the bank: 1.93B vs. GMED (518M). GMED has less debt than HOLX: GMED (520M) vs HOLX (2.58B). HOLX has higher revenues than GMED: HOLX (3.97B) vs GMED (1.57B).
GMEDHOLXGMED / HOLX
Capitalization7.19B17.9B40%
EBITDA347M1.06B33%
Gain YTD-5.3676.760-79%
P/E Ratio49.6536.08138%
Revenue1.57B3.97B40%
Total Cash518M1.93B27%
Total Debt520M2.58B20%
FUNDAMENTALS RATINGS
GMED vs HOLX: Fundamental Ratings
GMED
HOLX
OUTLOOK RATING
1..100
1618
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
75
Overvalued
PROFIT vs RISK RATING
1..100
8725
SMR RATING
1..100
8670
PRICE GROWTH RATING
1..100
6055
P/E GROWTH RATING
1..100
2131
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

HOLX's Valuation (75) in the Medical Specialties industry is in the same range as GMED (78). This means that HOLX’s stock grew similarly to GMED’s over the last 12 months.

HOLX's Profit vs Risk Rating (25) in the Medical Specialties industry is somewhat better than the same rating for GMED (87). This means that HOLX’s stock grew somewhat faster than GMED’s over the last 12 months.

HOLX's SMR Rating (70) in the Medical Specialties industry is in the same range as GMED (86). This means that HOLX’s stock grew similarly to GMED’s over the last 12 months.

HOLX's Price Growth Rating (55) in the Medical Specialties industry is in the same range as GMED (60). This means that HOLX’s stock grew similarly to GMED’s over the last 12 months.

GMED's P/E Growth Rating (21) in the Medical Specialties industry is in the same range as HOLX (31). This means that GMED’s stock grew similarly to HOLX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GMEDHOLX
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 1 day ago
66%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
56%
Bullish Trend 1 day ago
67%
MACD
ODDS (%)
Bearish Trend 1 day ago
60%
Bearish Trend 1 day ago
62%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
59%
Bearish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
55%
Bullish Trend 1 day ago
59%
Advances
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
58%
Declines
ODDS (%)
Bearish Trend 13 days ago
57%
Bearish Trend 7 days ago
54%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
63%
Aroon
ODDS (%)
Bearish Trend 1 day ago
51%
Bullish Trend 1 day ago
55%
View a ticker or compare two or three
Ad is loading...
GMEDDaily Signal changed days agoGain/Loss if shorted
 
Show more...
HOLXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
KYMR36.242.62
+7.79%
Kymera Therapeutics
PHAT9.260.23
+2.55%
Phathom Pharmaceuticals
WWD165.763.40
+2.09%
Woodward
AUUD1.640.01
+0.61%
Auddia
FNGR3.48-0.02
-0.57%
FingerMotion

HOLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HOLX has been loosely correlated with ABT. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if HOLX jumps, then ABT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HOLX
1D Price
Change %
HOLX100%
+0.67%
ABT - HOLX
43%
Loosely correlated
+0.30%
MDT - HOLX
42%
Loosely correlated
+0.81%
GMED - HOLX
42%
Loosely correlated
+1.29%
TMO - HOLX
42%
Loosely correlated
+1.10%
BDX - HOLX
41%
Loosely correlated
-0.38%
More